Dave Bloom
Dave Bloom is CEO and "Blogger in Chief" of SnackSafely.com.
This Year’s Federal Budget Increases Spending For Food Allergy Research and School Safety Efforts
Budget includes millions of dollars to increase food allergy research funding and protect children with food allergies.
Peanut Allergy Immunotherapy Toothpaste Makes Strides Toward Phase 2 Trial
Phase 1 study amended after two cohorts show no significant adverse events.
Easter Kit Recall Exposes Serious Ambiguity in US Allergen Labeling Regulations
The problem underlying the recall is not as clear-cut as stated on the FDA's website.
Public Health Organization Calls for Allergen Thresholds to Guide Product Labeling
Acceptable thresholds for allergen trace would make labeling safer and more reliable for the food allergy community.
HS Sophomore Launches Non-Profit to Outfit Restaurants with Epinephrine Auto-Injectors
"Safe Eats" will reimburse restaurants for the cost of stock epinephrine auto-injectors and train their staff to administer them.
Researchers Discover Key Source of Allergies and Anaphylaxis
Ground breaking science points the way toward new therapies for allergic disorders.
Professor of Emergency Medicine Warns Colleagues: Stop Playing Games with Anaphylaxis
A reminder to ER doctors and patients alike: Epinephrine should be the first-line treatment for anaphylaxis.
Lisa Horn Chats with Dave Bloom About Allergies, Labeling, and SnackSafely on “Food Allergy...
We discuss food allergies, allergen labeling, our petition, FALCPA, and other topics on the Food Allergy Talk podcast.
Starbucks Sued by Customers: One Suffered Allergic Reaction, the Other Served Cleaning Fluid
We provide strategies for protecting yourself from similar occurrences.
Stealth Mode Company Granted Patent for Sublingual Epinephrine Tablet
We've been reporting on the progress of AQST-109 by Aquestive Therapeutics, a postage-stamp-sized film placed under the tongue that provides epinephrine in an anaphylactic...
